Jaffetilchin Investment Partners’s Korro Bio KRRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-945
Closed -$31.6K 861
2024
Q3
$31.6K Buy
+945
New +$39.8K ﹤0.01% 664
2023
Q4
Sell
-931
Closed -$17.2K 365
2023
Q3
$17.2K Hold
931
﹤0.01% 337
2023
Q2
$16.1K Sell
931
-3
-0.3% -$58 ﹤0.01% 358
2023
Q1
$23.5K Buy
934
+16
+2% +$1.82K ﹤0.01% 352
2022
Q4
$177K Sell
918
-45
-5% -$4.63K 0.02% 328
2022
Q3
$86K Buy
963
+13
+1% +$1.32K 0.01% 309
2022
Q2
$71K Hold
950
0.01% 321
2022
Q1
$59K Buy
950
+423
+80% +$80.8K 0.01% 316
2021
Q4
$135K Buy
527
+4
+0.8% +$1.22K 0.01% 337
2021
Q3
$185K Sell
523
-366
-41% -$144K 0.02% 345
2021
Q2
$954K Buy
889
+488
+122% +$238K 0.07% 174
2021
Q1
$190K Sell
401
-4
-1% -$7.77K 0.02% 343
2020
Q4
$713K Buy
+405
New +$535K 0.1% 132

Other funds holding KRRO

Jaffetilchin Investment Partners's KRRO Position: Q4 2024 in Review

Jaffetilchin Investment Partners sold out of Korro Bio (KRRO) in Q4 2024, closing a stake of 945 shares — an estimated $31.6K sold.

Jaffetilchin Investment Partners first reported a position in KRRO in Q4 2020 and held it in 13 quarters. The position peaked at $954K in Q2 2021. 84 funds tracked by Wall St. Rank hold KRRO as of Q4 2024.

  • Jaffetilchin Investment Partners reported no remaining Korro Bio position as of Q4 2024 after selling out during the quarter.
  • Jaffetilchin Investment Partners sold 945 Korro Bio shares in Q4 2024, an estimated $31.6K.
  • Jaffetilchin Investment Partners first reported a position in Korro Bio in Q4 2020 and held it in 13 quarters.
  • Jaffetilchin Investment Partners's Korro Bio position peaked at $954K in Q2 2021.
  • 84 funds tracked by Wall St. Rank held Korro Bio as of Q4 2024.

Based on Jaffetilchin Investment Partners's 13F filing for Q4 2024, filed 13 Feb 2025.